Application no. and date | 08005013.1 (espacenet) (Federated) (European Patent Register), 19970801 | Patent/reg. no. and date | DK/EP 1941904, 20120516 | Publication date | 20080709 | Priority no. and date | US 690775, 19960801 | EP pub. no. and date |
EP 1941904 20080709 | Effective date | | Applicant/owner | THE MATHILDA AND TERRENCE KENNEDY INSTITUTE OF RHEUMATOLOGY TRUST, 65 Aspenlea Road
Hammersmith, London W6 8LH, GB | Applicant ref. no. | P49951DK01 | Inventor | Feldman, Marc, 2 Church Street Highgate
London N6 4QT, GB, Maini, Ravinder Nath, 151 Castlenau Barnes
London SW13 9EW, GB | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | Opponent | | IPC Class | A61K 31/505 (2006.01) , A61K 38/17 (2006.01) , A61K 39/395 (2006.01) , A61P 19/02 (2006.01) , A61P 37/06 (2006.01) , C07K 14/705 (2006.01) , C07K 16/24 (2006.01) | Title | TNF-antagonister til anvendelse i supplementsterapi til methotrexat i behandlingen af autoimmune sygdomme | Int. application no. | | Int. publication no. | | Related patent (certificate) | CA 2012 00046 | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - | Application no. and date | 08005013.1 (espacenet) (Federated) (European Patent Register), 19970801 | Patent/reg. no. and date | DK/EP 1941904, 20120516 | Publication date | 20080709 | Priority no. and date | US 690775, 19960801 | EP pub. no. and date |
EP 1941904 20080709 | Effective date | | Applicant/owner | THE MATHILDA AND TERRENCE KENNEDY INSTITUTE OF RHEUMATOLOGY TRUST, 65 Aspenlea Road
Hammersmith, London W6 8LH, GB | Applicant ref. no. | P49951DK01 | Inventor | Feldman, Marc, 2 Church Street Highgate
London N6 4QT, GB, Maini, Ravinder Nath, 151 Castlenau Barnes
London SW13 9EW, GB | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | Opponent | | IPC Class | A61K 31/505 (2006.01) , A61K 38/17 (2006.01) , A61K 39/395 (2006.01) , A61P 19/02 (2006.01) , A61P 37/06 (2006.01) , C07K 14/705 (2006.01) , C07K 16/24 (2006.01) | Title | TNF-antagonister til anvendelse i supplementsterapi til methotrexat i behandlingen af autoimmune sygdomme | Int. application no. | | Int. publication no. | | Related patent (certificate) | CA 2012 00047 | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|